Pharma channel feed – Endpoints News

Pharma channel feed

GSK plots regulatory filings for PBC itch after positive Phase 3 readout

5 months ago

NICE has 'done all we can' to negotiate for Enhertu coverage, reaffirms decision not to recommend

5 months ago

FDA rejects Astellas’ effort to support longer use of eye drug Izervay

5 months ago

Ahead of adcomm, FDA raises safety questions for AstraZeneca’s reversal agent for life-threatening bleeds

5 months ago

BeiGene settles final suit over future Brukinsa generics

5 months ago

Lawmakers are poking holes in pharma's favorite new way to market medicines

5 months ago

Drugmakers 'not doing everything that they could' to widen global access, new report finds

5 months ago

Merck finally has subcutaneous Keytruda results, and it's going to regulators

5 months ago

Exclusive: Synapticure raises $25M for its approach to virtual neurodegenerative disease care

5 months ago

Syndax's Revuforj wins FDA approval in aggressive form of leukemia

5 months ago

A rare neurological disease is Sage’s last, best hope after failures in depression

5 months ago

Novartis strikes radiopharma deal with Ratio worth up to $745M

5 months ago

Eisai terminates Phase 3 trial of Dravet drug, citing recruitment challenges

5 months ago

European drug regulators offer wave of positive recommendations following Leqembi reversal

5 months ago

Adaptimmune to 'redefine' itself as a sarcoma biotech, cuts a third of staffers

5 months ago

Eli Lilly sues the US government over its proposed 340B rebate model

5 months ago

Trump picks vaccine skeptic Kennedy to lead HHS, in what would be an upheaval of US health policy

5 months ago

FDA says Merz's social media promotion with Nate Berkus is 'misleading'

5 months ago

Gilead will close Philadelphia, Seattle offices as part of job reductions

5 months ago

European drug regulator reverses opinion on Eisai and Biogen's Alzheimer's drug

5 months ago

Louisiana's Bill Cassidy named next chair of Senate health committee

5 months ago

As bluebird projects more commercial demand, the biotech continues to seek cash

5 months ago

BeiGene will rebrand to BeOne Medicines, dropping name's link to China roots

5 months ago

Merck KGaA’s life science unit is still feeling the Covid demand decline

5 months ago

First page Previous page 22 23 242526 27 28 Next page Last page